Journal Information

Statistics

Follow this link to access the full text of the article

ORIGINALS
Economic evaluation and budgetary burden of mepolizumab in severe refractory eosinophilic asthma
Evaluacion economica y análisis de impacto presupuestario de mepolizumab en asma eosinofílica refractaria grave
Leticia García-Mochón1,1,1,1,*, Manuel David Gil-Sierra2,3,
,
, Emilio Jesús Alegre-del Rey2, Catalina Alarcón de la Lastra-Romero3, Marina Sánchez-Hidalgo3
1 Andalusian School of Public Health, Granada. Spain
1 Biomedical Research Center at Ciber for Epidemiology and Public Health (CIBERESP by its Spanish acronym), Madrid. Spain
1 IBS Biomedical Research Institute, Granada, Spain
1 University Hospitals of Granada/University of Granada, Granada. Spain
2 Pharmacy Service, Puerto Real University Hospital, Puerto Real. Spain
3 Department of Pharmacology, School of Pharmacy, University of Seville, Seville. Spain
Read
1806
Times
was read the article
510
Total PDF
1296
Total HTML
Share statistics
Article information
ISSN: 11306343
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 10 94 35 129
2025 9 98 20 118
2025 8 106 28 134
2025 7 101 30 131
2025 6 47 21 68
2025 5 77 32 109
2025 4 64 21 85
2025 3 62 28 90
2025 2 38 21 59
2025 1 44 22 66
2024 12 42 24 66
2024 11 51 21 72
2024 10 53 27 80
2024 9 68 23 91
2024 8 31 12 43
2024 7 39 20 59
2024 6 41 17 58
2024 5 46 23 69
2024 4 62 15 77
2024 3 51 12 63
2024 2 34 16 50
2024 1 12 10 22
2023 12 21 15 36
2023 11 14 17 31
Show all

Follow this link to access the full text of the article

Idiomas
Farmacia Hospitalaria